Rafarma Pharmaceuticals, Inc. (WY) (RAFA, $0.09) was a top loser over the last three months, falling -3 to $0.09 per share. A.I.dvisor analyzed 212 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending April 23, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.